A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
Lucknow: A simple blood test every three months could save the lives of Chronic Obstructive Pulmonary Disease (COPD) patients ...
Saphnelo, which generated $304 million in sales in the first half of this year, is projected to achieve peak annual sales of ...
China: Cardiac arrhythmias are frequent among patients hospitalized for acute exacerbations of chronic obstructive pulmonary ...
The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...
C hronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition—primarily chronic bronchitis and ...
For decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — ...
An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...
Women face a higher risk of lung damage compared to men, even if they have never smoked. Research shows that biological ...
Biologics targeting type 2 inflammation show strong efficacy in eosinophilic COPD, while non-type 2 approaches remain ...
To understand the hidden dimensions of COPD among non-smokers, The Week spoke with pulmonologist Dr Shahid Patel, consultant ...
On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback